Cite
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
MLA
Hill, Brian T., et al. “The Non-Relapse Mortality Rate for Patients with Diffuse Large B-Cell Lymphoma Is Greater than Relapse Mortality 8 Years after Autologous Stem Cell Transplantation and Is Significantly Higher than Mortality Rates of Population Controls.” British Journal of Haematology, vol. 152, no. 5, Mar. 2011, pp. 561–69. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2010.08549.x.
APA
Hill, B. T., Rybicki, L., Bolwell, B. J., Smith, S., Dean, R., Kalaycio, M., Pohlman, B., Tench, S., Sobecks, R., Andresen, S., Copelan, E., & Sweetenham, J. (2011). The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. British Journal of Haematology, 152(5), 561–569. https://doi.org/10.1111/j.1365-2141.2010.08549.x
Chicago
Hill, Brian T., Lisa Rybicki, Brian J. Bolwell, Stephen Smith, Robert Dean, Matt Kalaycio, Brad Pohlman, et al. 2011. “The Non-Relapse Mortality Rate for Patients with Diffuse Large B-Cell Lymphoma Is Greater than Relapse Mortality 8 Years after Autologous Stem Cell Transplantation and Is Significantly Higher than Mortality Rates of Population Controls.” British Journal of Haematology 152 (5): 561–69. doi:10.1111/j.1365-2141.2010.08549.x.